Illinois man is still hospitalized from a stroke he suffered just before Pfizer announced an Oxbryta recall in September 2024.
Following an Oxbryta recall issued last month, an Illinois man has filed a lawsuit alleging the manufacturer failed to adequately test the sickle cell anemia drug before rushing it to market.
Pfizer is recalling Oxbryta after at least eight patients died during clinical trials, which sparked a safety review by European drug regulators.
Structural racism, lack of healthcare access and other factors have led to half of children with sickle cell anemia not getting proper treatment, according to the researchers.
